![Jonathan Benjamin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Jonathan Benjamin worked as a Medical Director-Clinical Research at Amgen, Inc. from 2014 to 2017.
He then worked as a Vice President-Clinical Research at Atreca, Inc. before becoming an Assistant Professor at Stanford University School of Medicine.
Benjamin holds a graduate and doctorate degree from New York University and an undergraduate degree from Harvard College.
Antiguos cargos conocidos de Jonathan Benjamin.
Empresas | Cargo | Fin |
---|---|---|
ATRECA, INC. | Director Técnico/Científico/I+D | 01/07/2020 |
AMGEN INC. | Director Técnico/Científico/I+D | 01/03/2017 |
Stanford University School of Medicine | Corporate Officer/Principal | - |
Formación de Jonathan Benjamin.
Harvard College | Undergraduate Degree |
New York University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AMGEN INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Atreca, Inc.
![]() Atreca, Inc. BiotechnologyHealth Technology Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Jonathan Benjamin